Yuzuru Kanakura Selected Research

Yuzuru Kanakura Research Topics

Disease

17	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 04/2022 - 04/2002
14	Neoplasms (Cancer) 01/2021 - 05/2003
12	Multiple Myeloma 01/2022 - 01/2011
11	Hemolysis 04/2022 - 12/2006
9	Anemia 11/2022 - 06/2007
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 03/2002
5	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 08/2012
5	Infections 01/2020 - 01/2003
5	Thrombosis (Thrombus) 10/2013 - 05/2004
4	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 06/2007
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 11/2006
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 02/2003
4	Essential Thrombocythemia 11/2018 - 01/2007
4	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 01/2004
4	Inflammation (Inflammations) 01/2011 - 10/2002
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2006 - 08/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 06/2007
3	Bone Marrow Failure Disorders 08/2021 - 12/2018
3	Thrombocytopenia (Thrombopenia) 01/2020 - 04/2005
3	Headache (Headaches) 11/2018 - 10/2014
3	Genetic Translocation (Chromosomal Translocation) 01/2012 - 03/2002
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2009 - 08/2007
3	Lymphoma (Lymphomas) 10/2009 - 01/2008
3	Activated Protein C Resistance (APC Resistance) 03/2005 - 08/2002
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 09/2020 - 09/2012
2	Encephalitis (Encephalitis, Rasmussen) 08/2020 - 05/2018
2	Disease Progression 01/2020 - 01/2011
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 01/2012
2	Fibrosis (Cirrhosis) 01/2019 - 01/2009
2	Acute Promyelocytic Leukemia 12/2018 - 05/2003
2	Fever (Fevers) 05/2018 - 03/2010
2	Hemorrhage 01/2017 - 12/2015
2	Autoimmune Diseases (Autoimmune Disease) 12/2015 - 08/2003
2	Thrombasthenia (Glanzmann Thrombasthenia) 07/2013 - 01/2011
2	Pulmonary Hypertension 09/2012 - 08/2010
2	Fatigue 01/2011 - 11/2002
2	Dyspnea (Shortness of Breath) 01/2011 - 08/2010
2	Plasmacytoma 01/2011 - 01/2011
2	Leukemia 03/2009 - 05/2003
2	Venous Thrombosis (Deep-Vein Thrombosis) 05/2006 - 11/2002
2	Venous Thromboembolism 03/2005 - 08/2002
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2021

Drug/Important Bio-Agent (IBA)

14	eculizumab FDA Link 04/2022 - 01/2011
13	Proteins (Proteins, Gene)FDA Link 08/2021 - 04/2002
7	AntibodiesIBA 08/2020 - 08/2002
7	Monoclonal AntibodiesIBA 02/2015 - 01/2008
6	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2013
6	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 08/2021 - 04/2002
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2013
5	Complement System Proteins (Complement)IBA 09/2020 - 01/2011
5	Phosphotransferases (Kinase)IBA 01/2020 - 03/2008
5	Inosine Triphosphate (ITP)IBA 01/2020 - 08/2012
5	Messenger RNA (mRNA)IBA 09/2015 - 08/2007
5	Phospholipids (Phosphatides)FDA LinkGeneric 05/2006 - 08/2002
4	Hemoglobins (Hemoglobin)IBA 04/2022 - 10/2005
4	Melphalan (Alkeran)FDA LinkGeneric 02/2019 - 04/2014
4	Bortezomib (Velcade)FDA Link 01/2016 - 01/2011
4	Prothrombin (Factor II)IBA 05/2006 - 08/2002
3	TESIBA 11/2020 - 07/2020
3	ClathrinIBA 01/2020 - 01/2012
3	IronIBA 01/2019 - 10/2002
3	anagrelide (Agrylin)FDA LinkGeneric 11/2018 - 03/2013
3	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 04/2014
3	AutoantibodiesIBA 12/2015 - 08/2003
3	Immunoglobulin G (IgG)IBA 08/2012 - 08/2002
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2010 - 02/2003
3	AdiponectinIBA 06/2007 - 01/2006
3	PhosphatidylserinesIBA 05/2006 - 05/2004
3	Cardiolipins (Cardiolipin)IBA 05/2006 - 05/2004
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 03/2005 - 08/2002
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2005 - 08/2002
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 06/2014
2	Complement Inactivating AgentsIBA 10/2020 - 01/2011
2	Thrombopoietin ReceptorsIBA 01/2020 - 09/2013
2	Thrombopoietin (c-mpl Ligand)IBA 01/2020 - 10/2008
2	tyrosine receptor (receptor, tyrosine)IBA 01/2020 - 03/2008
2	GPI-Linked ProteinsIBA 12/2019 - 03/2008
2	CytokinesIBA 01/2019 - 04/2005
2	AntigensIBA 01/2018 - 10/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2016 - 09/2012
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2016 - 01/2007
2	SteroidsIBA 10/2016 - 09/2010
2	Tyrosine (L-Tyrosine)FDA Link 06/2016 - 03/2009
2	Pharmaceutical PreparationsIBA 01/2016 - 05/2013
2	Rituximab (Mabthera)FDA Link 12/2015 - 10/2009
2	Tyrosine Kinase InhibitorsIBA 09/2015 - 06/2014
2	Imatinib Mesylate (Gleevec)FDA Link 06/2014 - 07/2010
2	Transcription Factors (Transcription Factor)IBA 10/2013 - 12/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 01/2003
2	Anti-Idiotypic AntibodiesIBA 05/2006 - 05/2004
2	factor V LeidenIBA 11/2002 - 08/2002
1	Darbepoetin alfa (Aranesp)FDA Link 11/2022
1	carfilzomibIBA 01/2022
1	tesidolumabIBA 01/2022
1	ixazomibIBA 04/2021

Therapy/Procedure

21	Therapeutics 08/2021 - 01/2003
7	Drug Therapy (Chemotherapy) 10/2019 - 01/2004
5	Transplantation 07/2021 - 10/2016
4	Hematopoietic Stem Cell Transplantation 01/2021 - 01/2016
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2019 - 11/2006